In Depth 25 Sep 2023
Base editing hits the clinic in the U.S.
Over the past couple of years, base editing, a recent offshoot of the heralded CRISPR/Cas 9 technology, has been doing its rounds in the biotech space. Now, base editing has…
About
Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.
Articles by Roohi Mariam Peter
News and Trends 22 Sep 2023
U.S. approval for psychedelic drug MDMA nears after success in clinic
The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of a trial were published. This comes…
Best in Biotech 21 Sep 2023
Recent advancements in prostate cancer research over the past year
Prostate cancer is the second most commonly occurring cancer in men. More than 1.4 million people were diagnosed with prostate cancer in 2020, according to the World Cancer Research Fund…
News and Trends 18 Sep 2023
Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities
The U.K. is rejoining the European Union’s (EU’s) $100 billion research program Horizon Europe, after being locked out of the deal amid post Brexit tensions for more than two years.…
ADVERTISEMENT
In Depth 14 Sep 2023
Righting wrongs: genetic justice for Henrietta Lacks
For what would have been Henrietta Lacks’ 103rd birthday last month, her family, who settled a lawsuit with Thermo Fisher - a multinational biotech company that had used her cells without…
Best in Biotech 12 Sep 2023
Here are five biotech companies in Montreal to keep an eye on
Montreal, the largest city in Canada's Quebec province, has seen a boom in life sciences over the years. Home to The Biotech City, a hub that connects and supports biopharmaceutical…
In Depth 7 Sep 2023
Hope for patients with life-threatening muscle disorder after years of clinical trial failures
Duchenne muscular dystrophy is a rare condition that is typically treated with the help of steroids, to manage symptoms, as scientists are yet to close in on a cure. However,…
Best in Biotech 5 Sep 2023
Five recent advancements in ovarian cancer research over the past year
With around 7500 new cases reported in the U.K. alone every year, ovarian cancer may occur because of the inheritance of faulty genes like BRCA. Although the exact reason for…
In Depth 31 Aug 2023
3D-printed tumors: startup hopes to drive cancer drug discovery
3D printing is capturing attention in the field of medicine of late. With the first 3D-printed drug being approved for the treatment of seizures, eight years ago, it was a…
Best in Biotech 29 Aug 2023
Are these 10 biotech recruiters on your radar this year?
The process of hunting for recruits can be a struggle for many companies, particularly when they have an ideal candidate in mind. And many at times, for the life science/biotech…
ADVERTISEMENT
Best in Biotech 23 Aug 2023
Latest advancements in psoriasis research over the past year
Psoriasis, an autoimmune condition that causes flaky patches of skin to form scales, occurs when the body’s immune system attacks its own healthy skin cells. And because people with psoriasis…
Best in Biotech 17 Aug 2023
Six Toronto-based biotech companies to watch this year
The capital city of the Canadian province of Ontario, Toronto, is home to the Discovery District, a commercial hub that sees biotech and healthcare innovations and companies at its prime.…
In Depth 15 Aug 2023
Can stem cell treatment repair damaged knees?
Scientists’ fascination with amphibians like axolotls and newts, animals that are capable of scarlessly regrowing their limbs, sparked the idea of possibly replicating this in humans. Since 1958, when French…
In Depth 9 Aug 2023
Meet the startup working to help treat a rare pediatric cancer
Nearly 50% of the children diagnosed with neuroblastoma are considered high-risk, where the tumor has spread, making surgery no longer a viable treatment option. Owing to this stark statistic, the…
In Depth 3 Aug 2023
How is artificial intelligence rising to the challenge in breast cancer diagnosis?
The scope of artificial intelligence (AI) in medicine has been rapidly expanding in recent years. With AI shaping the way clinical research is conducted, it has also opened doors for…
Best in Biotech 1 Aug 2023
Top biotech books of all time
It’s summertime and what’s better than to curl up in bed, or under a shady tree, or by the pool, and read a good book? We have curated a list…
ADVERTISEMENT
Best in Biotech 28 Jul 2023
Six companies driving Chennai’s biotech scene
Just like Bangalore, the city of Chennai in the southern state of Tamil Nadu in India, is a key hub for the biotech industry in the country. Chennai, which runs…
In Depth 26 Jul 2023
Antibody drug conjugates: BiVictriX drives a new era in cancer medicine
The first-ever antibody-drug conjugate (ADC) to be approved, gemtuzumab ozogamicin, raised hope for a new class of drugs to treat cancer. But the drug was then withdrawn following a black…
In Depth 24 Jul 2023
Sarcoma research: is a breakthrough in sight?
Among the rarest forms of cancers, sarcomas develop in the bones and connective tissues that support structures in the body like blood vessels, nerves and joints. This year, around 13,400…
In Depth 18 Jul 2023
Ten years to ten days: French startup revolutionizes early diagnosis of endometriosis with a saliva test
A condition that affects around 190 million women and girls worldwide, according to the World Health Organization, endometriosis is a chronic, difficult-to-treat disease that causes debilitating pelvic pain. Often misdiagnosed…